Continue Reading
Full article on TechCrunch
OpenEvidence hits $12B valuation, with new round led by Thrive, DST
Market Intelligence Analysis
AI-Powered
Why This Matters
OpenEvidence, a medical information database, has reached a $12 billion valuation after a new funding round led by Thrive and DST, doubling its valuation since October. This achievement comes despite competition from model makers in the industry. The company's growth suggests a strong demand for its services.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
The medical info database has doubled in valuation since last raise in October, despite encroachment from model makers.
AI Breakdown
Summary
OpenEvidence, a medical information database, has reached a $12 billion valuation after a new funding round led by Thrive and DST, doubling its valuation since October. This achievement comes despite competition from model makers in the industry. The company's growth suggests a strong demand for its services.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Time Horizon
Short Term
Original article published by
TechCrunch
on January 21, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.